United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Oct 20, 2026 · Filed Oct 21, 2026

On Oct 20, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$553.87 for US$5.26M under a trading plan, leaving 324,443 shares. Filed Oct 21, 2026 (Form 4).

Sold
9,500 shares
Price
US$553.87 average (US$546.84 to US$563.56)
Value
US$5.26M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Oct 20, 2026Common StockOption exercise9,500US$117.76333,943Indirect
Oct 20, 2026Common StockSale117US$546.84333,826Indirect
Oct 20, 2026Common StockSale575US$547.79333,251Indirect
Oct 20, 2026Common StockSale948US$548.95332,303Indirect
Oct 20, 2026Common StockSale586US$550.02331,717Indirect
Oct 20, 2026Common StockSale1,134US$551.03330,583Indirect
Oct 20, 2026Common StockSale1,560US$551.85329,023Indirect
Oct 20, 2026Common StockSale240US$553.14328,783Indirect
Oct 20, 2026Common StockSale1,260US$553.97327,523Indirect
Oct 20, 2026Common StockSale160US$555.09327,363Indirect
Oct 20, 2026Common StockSale440US$556.06326,923Indirect
Oct 20, 2026Common StockSale320US$557.12326,603Indirect
Oct 20, 2026Common StockSale520US$558.72326,083Indirect
Oct 20, 2026Common StockSale280US$559.70325,803Indirect
Oct 20, 2026Common StockSale315US$560.67325,488Indirect
Oct 20, 2026Common StockSale360US$561.84325,128Indirect
Oct 20, 2026Common StockSale464US$562.78324,664Indirect
Oct 20, 2026Common StockSale221US$563.56324,443Indirect

Source

Download original · View original at SEC

Related